Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to -$0.02.

  • Northwest Biotherapeutics' EPS (Basic) changed 0.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year increase of 1428.57%. This contributed to the annual value of -$68.58 for FY2024, which is 11419917.69% down from last year.
  • As of Q3 2025, Northwest Biotherapeutics' EPS (Basic) stood at -$0.02, which was down 0.0% from -$0.01 recorded in Q2 2025.
  • Over the past 5 years, Northwest Biotherapeutics' EPS (Basic) peaked at $0.16 during Q4 2021, and registered a low of -$22.94 during Q4 2024.
  • Its 5-year average for EPS (Basic) is -$1.47, with a median of -$0.01 in 2022.
  • As far as peak fluctuations go, Northwest Biotherapeutics' EPS (Basic) surged by 14324.32% in 2021, and later crashed by 22929261.99% in 2024.
  • Quarter analysis of 5 years shows Northwest Biotherapeutics' EPS (Basic) stood at $0.16 in 2021, then tumbled by 112.5% to -$0.02 in 2022, then surged by 50.0% to -$0.01 in 2023, then crashed by 229292.62% to -$22.94 in 2024, then surged by 99.91% to -$0.02 in 2025.
  • Its EPS (Basic) was -$0.02 in Q3 2025, compared to -$0.01 in Q2 2025 and -$0.01 in Q1 2025.